Brooklyn Center, MN – According to filings with the U.S. Securities and Exchange Commission, ShiraTronics is raising $36,647,464.00 in new funding. Sources indicate as part of senior management Chief Executive Officer, Lynn Elliott played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About ShiraTronics

ShiraTronics is in the early stages of developing new innovative therapies to combat debilitating migraine headache. ShiraTronics is focused on commercializing novel neuromodulation technologies to treat this large unmet clinical need for patients and physicians. ShiraTronics is the first spinout from NuXcel a global medical device accelerator company. ShiraTronics is based in Minneapolis and Ireland.

To learn more about ShiraTronics, visit http://shiratronics.com/

Contact:
Lynn Elliott, Chief Executive Officer
763-772-2313
https://www.linkedin.com/in/lynn-elliott-0769955/

SOURCE: http://www.intelligence360.io
Copyright (c) 2020 SI360 Inc. All rights reserved